SCHEMBL26306829

SCHEMBL26306829

CC1(C)CCC(C)(C)c2c(Nc3cccc4ccccc34)cccc21

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP3A4 P08684 3/20 0.46
▸ TP53 P04637 2/20 0.46
▸ HSD17B10 Q99714 2/20 0.46
▸ CDC25B P30305 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ HPGD P15428 1/20 0.46
▸ ALOX15 P16050 1/20 0.46
▸ TSHR P16473 1/20 0.46
▸ ATM Q13315 1/20 0.46
▸ RAB9A P51151 1/20 0.42
▸ GAA P10253 3/20 0.40
▸ KDM4E B2RXH2 3/20 0.40
▸ MAPT P10636 3/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP2D6 P10635 2/20 0.40
▸ CYP2C9 P11712 2/20 0.40
▸ CYP2C19 P33261 2/20 0.40
▸ CASP1 P29466 1/20 0.40
▸ CCR4 P51679 4/20 0.40
▸ MAPK1 P28482 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24005343 0.87 TP53 (0.43) TP53CYP1A2MEN1KMT2A
SCHEMBL27395067 0.81 ALDH1A1 (0.41) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL24292884 0.81 MEN1 (0.41) TP53ALDH1A1HPGDRAB9AMAPT
SCHEMBL26006466 0.79 MEN1 (0.46) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL26306675 0.78 RAB9A (0.52) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL29336481 0.78 ALDH1A1 (0.44) CYP3A4HSD17B10ALDH1A1HPGDRAB9A
SCHEMBL49213 0.75 HSD17B10 (0.74) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL31375644 0.74 RARB (0.40) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL25491148 0.74 RARB (0.40) CYP3A4TP53HSD17B10CDC25BALDH1A1
SCHEMBL23446728 0.74 RARB (0.39) TP53CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 — — US disclosed
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2024-07-23 — — US disclosed
WO-2023160121-A1 ORGANIC COMPOUND, ELECTRONIC ELEMENT COMPRISING SAME, AND ELECTRONIC DEVICE 陕西莱特光电材料股份有限公司 2023-08-31 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12048240-B2 Organic compound, electronic component and electronic apparatus comprising the same PIEZO1, OCIAD1, OSTC CYP3A4 138/4885TP53 3267/4885HSD17B10 2031/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback